Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

Hans van Bruggen

portrait

Hans van Bruggen is CEO of and Senior Regulatory Affairs Scientist at Qdossier. He holds an MSc. in Pharmaceutical Medicine from the University of Surrey (UK) and has worked in the pharmaceutical industry for more than 35 years, primarily at global or European headquarters sites. He has gained a wealth of experience and a comprehensive view on what information is needed to evaluate the benefit/risk ratio of drugs for patients and healthy volunteers. He approaches interdisciplinary and international processes using that scientific background. He applies new technologies and Artificial Intelligence to facilitate the business and let people focus on what they can do best.

Biosimilars Training Course

Biosimilars

4-5 Jul 2022

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

The Common Technical Document Training Course

The Common Technical Document

18-19 Jul 2022

A comprehensive review of the regulations and technical requirements for chemistry, manufacturing and control (CMC) management of your application.

The FDA (Food and Drug Administration) Drug Approval Process Training Course

The FDA Drug Approval Process

19-20 Sep 2022

A comprehensive overview of FDA procedures, requirements for marketing authorisations and recent developments affecting the drug approval process in the US

Biosimilars Training Course

Biosimilars

11-12 Oct 2022

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

The Common Technical Document Training Course

The Common Technical Document

28-29 Nov 2022

A comprehensive review of the regulations and technical requirements for chemistry, manufacturing and control (CMC) management of your application.